- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02328534
Semen Processing for ICSI Using Swim-down and Density Gradient Methods
Novel Approach of Semen Preparation to Improve ICSI Outcome.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is different semen processing method, in this study we compared the ICSI output when the investigators used one method with higher separation method and minimum sperm stress or physical interface as swimming down using 100 % silica solution, with other more stressful procedure with high selection power as density gradient.
The routine used method as density gradient (DG) includes about 30 min centrifugation at 1200 RPM, and more working steps with more handling procedures. According to many references the investigators can approve that it is method to be indicated with all cases particularly with those severely decreases semen number or motility.
Using 100 % silica solution for semen processing used for ICSi, shews lesser centrifugation time and minimum processing procedures. As swimming down time is about 30 min followed by 5 min washing and finalized with other 3 minutes last wash. For that total interfering physical action is about 8 minutes compared with 30 min with DG method.
In swimming down we are using the natural sperm behavior and own swimming power for separate itself from other seminal components. As well as only the one normally structure and motility direction the only can penetrate the interface surface of silica solution and swim inside higher density matrix using its speed and power.
Study Type
Enrollment (Actual)
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria: all semen samples fresh or frozen that has,
- Cases have semen examination criteria fall within WHO 2010 standards of count
- Cases have semen examination criteria fall within WHO 2010 standards of motility
- Cases have semen examination criteria with all types of abnormal forms
- Cases produced more than 4 mature oocytes (M2) and more
Exclusion Criteria:
- Cases have semen examination criteria with motility less than 5%
- Cases have semen examination criteria with count less than 1.0 million
- Cases with TESE, TESA and EPSA, both fresh and frozen
- Cases produced less than 4 mature oocytes (M2)
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Density Gradient semen
ICSI Cases processed using DG semen processing and evaluated by Blastocyst Formation Rate Blastocyst Rate Pregnancy Rate |
Embryos developed at Day3 cultures, are continued for Day5 culture tho reach blastocyst stage. The percentage of blastocyst produced from cleaved embryos to be evaluated ar rate. The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.
Other Names:
Day 5 embryo transfer achieved pregnancy are compared with total embryo transfer cases at Day5. The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time. Pregnancy confirmed with day 12 after Et and repeated with 48 hours after 1st exam.
Other Names:
All pregnancy achieved from all ET. Pregnancy confirmed with day 12 after Et and repeated with 48 hours after 1st exam. The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.
Other Names:
|
Swimming down semen
ICSI Cases processed using SD semen processing and evaluated by Blastocyst Formation Rate Blastocyst Rate Pregnancy Rate |
Embryos developed at Day3 cultures, are continued for Day5 culture tho reach blastocyst stage. The percentage of blastocyst produced from cleaved embryos to be evaluated ar rate. The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.
Other Names:
Day 5 embryo transfer achieved pregnancy are compared with total embryo transfer cases at Day5. The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time. Pregnancy confirmed with day 12 after Et and repeated with 48 hours after 1st exam.
Other Names:
All pregnancy achieved from all ET. Pregnancy confirmed with day 12 after Et and repeated with 48 hours after 1st exam. The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Pregnancy Rate
Time Frame: 3 Years
|
Percentage of Pregnancies developed after embryo transfer, for maternal age less than 38 years old.
|
3 Years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blastulation Rate (BR)
Time Frame: 3 years
|
Percentage of blastocyst embryos produced from cleaved embryos, for maternal age less than 38 YO.
|
3 years
|
Blastocyst formation Rate (BFR)
Time Frame: 3 Years
|
Developed embryos developed to Blastocyst stage from cleaved embryos.
|
3 Years
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ahmad M Metwalley, Ms. Genetics, Adliyah
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AlBarakaSD1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Blastocyst Formation Rate
-
Ibn Sina HospitalBanoon IVF Center; Quena IVF CentreCompleted
-
Chen Zi-JiangThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsUnknown
-
University of AarhusAarhus University HospitalCompleted
-
Antalya IVFWithdrawn
-
Bruce Shapiro M.D.Completed
-
Des Moines UniversityCompleted
-
Fertility Center of Las VegasFerring PharmaceuticalsCompletedInfertilityUnited States
-
Fertility Center of Las VegasSchering-PloughCompletedInfertilityUnited States
-
V.K.V. American Hospital, IstanbulCompleted
-
Ibn Sina HospitalBanon IVF Center Assiut, EgyptCompleted